We found that RBPs improved hepatic steatosis, as shown by the alterations in the liver morphology (reduced liver weight), histology (reduced lipid droplet accumulation), and serum biochemical tests (reduced content of ALT, TBA, and TBIL). The gene discussed is GPT; the disease is fatty liver disease.